17 February 2022
Latham & Watkins Advises TPG Capital in Majority Investment in Confluent Medical Technologies
Advising firms
Deal team
33 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Neal Reenan Lead | Latham & Watkins LLP | Partner | private equity M&A | Boston |
| Ian Bushner Lead | Latham & Watkins LLP | Partner | private equity M&A | Chicago |
| Manu Gayatrinath Lead | Latham & Watkins LLP | Partner | private equity finance | Washington, D.C. |
| Madisson Goorman | Latham & Watkins LLP | Associate | private equity M&A | Not stated |
| Karysa Norris | Latham & Watkins LLP | Associate | private equity M&A | Not stated |
| Jase Burner | Latham & Watkins LLP | Associate | private equity M&A | Not stated |
| Jennifer Boyd | Latham & Watkins LLP | Associate | private equity M&A | Not stated |
| Jake Wasserman | Latham & Watkins LLP | Associate | private equity M&A | Not stated |
| Jennifer Kent | Latham & Watkins LLP | Associate | private equity finance | Not stated |
| Zachary Anderson | Latham & Watkins LLP | Associate | private equity finance | Not stated |
| Dalton Downing | Latham & Watkins LLP | Associate | private equity finance | Not stated |
| Zach Lippman | Latham & Watkins LLP | Associate | private equity finance | Not stated |
| Katharine Moir | Latham & Watkins LLP | Partner | tax | Bay Area |
| Alex Farris | Latham & Watkins LLP | Associate | tax | Not stated |
| Ben Haas | Latham & Watkins LLP | Partner | FDA regulatory | Washington, D.C. |
| Seth Olson | Latham & Watkins LLP | Associate | FDA regulatory | Not stated |
| Nicole Liffrig Molife | Latham & Watkins LLP | Counsel | healthcare regulatory | Washington, D.C. |
| Margaret Rote | Latham & Watkins LLP | Associate | healthcare regulatory | Not stated |
| Allen Gardner | Latham & Watkins LLP | Partner | product liability | Washington, D.C. |
| Jeremiah Wolsk | Latham & Watkins LLP | Partner | intellectual property | Washington, D.C. |
| Ryan Sanders | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Robert Blamires | Latham & Watkins LLP | Counsel | data privacy | Bay Area |
| Adriana Beach | Latham & Watkins LLP | Associate | data privacy | Not stated |
| Jennifer Pepin | Latham & Watkins LLP | Partner | benefits and compensation | New York |
| Jina Davidovich | Latham & Watkins LLP | Associate | benefits and compensation | Not stated |
| Jeffrey Anderson | Latham & Watkins LLP | Counsel | real estate | Chicago |
| James Barrett | Latham & Watkins LLP | Partner | environmental | Washington, D.C. |
| Phil Sandick | Latham & Watkins LLP | Associate | environmental | Not stated |
| Meredith Monroe | Latham & Watkins LLP | Partner | anti-corruption | Chicago |
| Joseph Grosser | Latham & Watkins LLP | Associate | anti-corruption | Not stated |
| Drew Levin | Latham & Watkins LLP | Partner | representation and warranty insurance | Los Angeles |
| Harrison White | Latham & Watkins LLP | Associate | representation and warranty insurance | Not stated |
| Elisabeth Martin | Latham & Watkins LLP | Partner | capital markets | Boston |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- TPG CapitalInvestor
- Counterparties
- Confluent Medical Technologies (Sell-side)